Last reviewed · How we verify
CNTO 95 and avastin
At a glance
| Generic name | CNTO 95 and avastin |
|---|---|
| Also known as | bevacizumab |
| Sponsor | Herbert Hurwitz, MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CNTO 95 and avastin CI brief — competitive landscape report
- CNTO 95 and avastin updates RSS · CI watch RSS
- Herbert Hurwitz, MD portfolio CI